| 英文名称 | 中文名称 | CAS | MF |
|
(1R,2R,3S,6S,7S)-Tricyclo[5.2.1.02,6]decane-3β-ol
|
|
|
|
|
(1R,2R,4S,5S)-7β-[[[(S)-2-Hydroxy-1-phenylethyl]carbonyl]oxy]-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonane 9-oxide
|
|
|
|
|
Ertapenem
|
厄他培南
|
153832-46-3
|
C22H25N3O7S
|
|
(3R,5R,8S,9S,10S,13S,14S,17R)-17-[(1R)-1,2-dihydroxyethyl]-3,17-dihydr oxy-10,13-dimethyl-2,3,4,5,6,7,8,9,12,14,15,16-dodecahydro-1H-cyclopen ta[a]phenanthren-11-one
|
Β-皮甾酮四醇
|
667-66-3
|
C21H34O5
|
|
(3R,5R,8S,9S,10S,11S,13S,14S,17S)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12 ,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,11,17-triol
|
|
20685-55-6
|
C19H32O3
|
|
(2R,3R,4S,5S,6S)-2-[(1R)-1,2-dihydroxyethyl]-6-[(2R,3S,4S,5S,6R)-6-[(1 R)-1,2-dihydroxyethyl]-2,5-dihydroxy-2-methyl-4-[(2R,3R,4S,5R,6R)-3,4, 5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-oxan-3-yl]oxy-oxane-3,4,5- triol
|
|
131289-51-5
|
C21H38O18
|
|
(2R,3R,4S,5S,6S)-2-[(2R,3S,4R,5R)-3,4-dihydroxy-2,5-bis(hydroxymethyl) oxolan-2-yl]oxy-6-(sulfanylmethyl)oxane-3,4,5-triol
|
|
92596-11-7
|
C12H22O10S
|
|
（1R，2R，4S，5S，7s)-7-[2-hydroxy-2,2-di(2-thienyl)acetoxy]-9-methyl-3-oxatricyclo[3.3.1.02,4]nonane
|
(1R,2R,4S,5S,7S)-7-[2-羟基-2,2-二(2-噻吩基)乙酰氧基]-9-甲基-3-氧杂三环[3.3.1.0 2,4] 壬烷
|
|
|
|
(8R,9R,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-17-(2-methylprop-2-enyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
|
|
2824-50-2
|
C23H34O2
|
|
(8R,9R,10S,13S,14S)-3-hydroxy-13-methyl-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1H-cyclopenta[a]phenanthren-17-one
|
(8R,9R,10S,13S,14S)-3-hydroxy-13-methyl-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1H-cyclopenta[a]phenanthren-17-one
|
1225-01-0
|
C18H28O2
|
|
(3R,4R,6S,7S,11S,12R)-7,11-Dibromo-6-chloro-7,10,10-trimethyl-1-oxadispiro[2.0.5.4]tridecan-12-ol
|
|
|
C15H23Br2ClO2
|
|
(2R,3R,2'S,3'S)-1'-[(1S)-2-Hydroxy-1-methylethyl]-2α,2'β-diphenyl-3α-phenoxy-1,3'-biazetidine
|
|
|
|
|
(5β,8R,10α,13R,14S)-14-(Tigloyloxy)-3α-acetoxybeyera-15-ene-18-oic acid
|
|
|
|
|
(5β,8R,10α,13R,14S)-14-(Tigloyloxy)-3α-acetoxybeyer-15-en-18-oic acid methyl ester
|
|
|
|
|
(5β,8R,10α,13R,14S)-14-(Tigloyloxy)-18-hydroxybeyer-15-ene
|
|
|
|
|
(5β,8R,10α,13R,14S)-14-(Tigloyloxy)beyer-15-ene-3α,18-diol
|
|
|
|
|
(5β,8R,10α,13R,14S)-14-(Tigloyloxy)beyer-15-en-18-oic acid
|
|
|
|
|
(5β,8R,10α,13R,14S)-14-(Tigloyloxy)-3α,19-(isopropylidenebisoxy)beyer-15-ene
|
|
|
|
|
(1R,5R,6S,7S,8S)-7-Acetoxy-8-iodo-6-(methoxymethyl)-2-oxabicyclo[3.3.0]octan-3-one
|
|
|
C11H15IO5
|
|
(2R,3R,2'S,3'S)-1'-[(1S)-2-Hydroxy-1-methylethyl]-2α,2'β-diphenyl-3α-hydroxy-1,3'-biazetidine
|
|
|
|
|
(5β,8R,10α,13R,14S)-14-(Tigloyloxy)-3α-hydroxybeyer-15-en-18-oic acid
|
|
|
|
|
(1R,2R,6S,7S)-Tricyclo[5.2.1.02,6]deca-3,8-diene-9-carboxylic acid ethyl ester
|
|
|
C13H16O2
|
|
(R)-2-[[(2R,4S,5S)-5-(tert-Butoxycarbonylamino)-2-benzyl-4-hydroxy-6-phenylhexanoyl]amino]-4-methylpentanamide
|
|
|
C30H43N3O5
|
|
(1R,2R,6S,7S)-Tricyclo[5.2.1.02,6]deca-3,8-diene-8-carboxylic acid ethyl ester
|
|
|
C13H16O2
|
|
(1R,2R,6S,7S)-Tricyclo[5.2.1.02,6]deca-3,8-diene-9-carbaldehyde
|
|
|
C11H12O
|
|
(1R,3R,5S,7S)-1,3,5,7-Tetramethyl-2-thiatricyclo[3.3.1.13,7]decane-4,6,8-trione
|
|
|
|
|
(1R,2R,6S,7S)-Tricyclo[5.2.1.02,6]deca-3,8-diene-8-carbaldehyde
|
|
|
C11H12O
|
|
(1R,2R,3S,5S)-3-(TERT-BUTYL-DIMETHYL-SILANYLOXY)-2-HEXYL-5-UNDECYL-CYCLOPENTANOL
|
|
|
C28H58O2Si
|
|
[1R-(1R*,5S*,9S*)]-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undec-3-en-5-yl acetate
|
|
67843-79-2
|
C17H26O2
|
|
[1R-(1R*,5S*,9S*)]-4,11,11-trimethyl-8-methylenebicyclo[7.2.0]undecen-5-yl formate
|
|
85136-29-4
|
C16H24O2
|
|
[(2R,3R,4S,5S)-3,4,5,6-tetrahydroxyoxan-2-yl]methoxyphosphonic acid
|
(2R,3R,4S,5S)-3,4,5,6-四羟基四氢吡喃-2-基]甲氧基膦酸
|
3672-15-9
|
C6H13O9P
|
|
(1R,3R,4S,6S)-4-TERT-BUTOXYCARBONYLAMINO-4,7,7-TRIMETHYL-BICYCLO[4.1.0]HEPTANE-3-CARBOXYLIC ACID
|
(1R,3R,4S,6S)-4-TERT-BUTOXYCARBONYLAMINO-4,7,7-TRIMETHYL-BICYCLO[4.1.0]HEPTANE-3-CARBOXYLIC ACID
|
654680-62-3
|
C16H27NO4
|
|
Rsk1, active (MAPKAP K1a, Kinase 1a)
|
|
|
|
|
Rsk3, active, Recombinant, Human (Ribosomal S6 Kinase 3)
|
|
|
|
|
Rsk1, active, Recombinant, Human (Ribosomal S6 Kinase 1, MAPKAP K1a, Kinase1a)
|
|
|
|
|
Rsk2, active, Recombinant, Human (Ribosomal S6 Kinase 2, MAPKAP K1b, Kinase1b)
|
|
|
|
|
Rsk1, active, Recombinant, Rat (Ribosomal S6 Kinase 1, MAPKAP K1a, Kinase1a)
|
|
|
|
|
(2R,4'R,8'S)-5,7,8-Trimethyltocol
|
|
|
|
|
(2R,3R,4S)-2,3,4-Trimethoxy-5-hexenal
|
|
|
C9H16O4
|
|
(1R,5R,7S)-Tricyclo[5.4.0.01,5]undecane-8-one
|
|
|
C11H16O
|
|
(2R)-2-[(4R,8S)-4,8,12-Trimethyltridecyl]-2,5,7-trimethyl-3,4-dihydro-2H-1-benzopyran-6-ol
|
|
|
C28H48O2
|
|
(2R)-2-[(4R,8S)-4,8,12-Trimethyltridecyl]-2,7,8-trimethyl-3,4-dihydro-2H-1-benzopyran-6-ol
|
|
|
C28H48O2
|
|
(2R,3R,4S)-2-Triphenylmethoxy-4-methyl-5-hexen-3-ol
|
|
|
C26H28O2
|
|
(1R,3R,4S)-3-(Triethylsiloxy)-p-menthane
|
|
|
C16H34OSi
|
|
3-[(1R,2R,4S)-1,7,7-Trimethylbicyclo[2.2.1]heptan-2β-yl]cyclohexanol
|
|
|
|
|
(22R,23R,24S)-3β,22,23-Trihydroxy-5α-ergostan-6-one
|
|
92751-21-8
|
C28H48O4
|
|
(22R,23R,24S)-3α,22,23-Trihydroxy-5α-ergostan-6-one
|
|
87734-68-7
|
C28H48O4
|
|
(2R)-2-[(4R,8S)-4,8,12-Trimethyltridecyl]-2,8-dimethyl-3,4-dihydro-2H-1-benzopyran-6-ol
|
|
|
C27H46O2
|
|
(2R,3R,4S)-2,3,4-trihydroxy-4-(2-phenyl-2H-1,2,3-triazol-4-yl)butyl 4-methylbenzenesulfonate
|
|
|
C19H21N3O6S
|
|
(1R,4R,10S)-4,12,12-TRIMETHYL-9-METHYLENE-5-OXA-TRICYCLO[8.2.0.0(4,6)]DODECANE
|
|
|
C15H24O
|
|
(1R,2R)-1-Styryl-2-methyl-2-vinyl-1,3-propanediol
|
|
|
C14H18O2
|
|
rSIVp55
|
|
|
|
|
RSK-B protein
|
|
|
|
|
(R)-TaClo
|
|
175779-28-9
|
C12H11Cl3N2
|
|
(R)-TaClo
|
(R)-TaClo
|
175779-27-8
|
C12H11Cl3N2
|
|
rRTNC
|
|
|
|
|
RT1Ac (MHC Class I)
|
|
|
|
|
rrTNF-a
|
重组大鼠TNF-Α
|
|
|
|
RSK3, CT (Ribosomal S6 Kinase 3)
|
|
|
|
|
RSK2, CT (Ribosomal S6 Kinase 2)
|
|
|
|
|
(2R, 4R)-4-(TOLUENE-4-SULFONYLOXY)-1-[BENZYLOXYCARBONYL]-PYRROLIDINE-2-ETHYLCARBOXYLATE
|
|
130830-60-3
|
C22H25NO7S
|
|
(1R,4R,7-syn)-2α-Bromo-5-oxobicyclo[2.2.1]heptane-7-carboxylic acid
|
|
|
|
|
(1R,4R,7-syn)-2α-Chloro-5-oxobicyclo[2.2.1]heptane-7-carboxylic acid
|
|
|
|
|
(1R,4R,7-syn)-1,7-Dimethyl-7-(4-methyl-3-pentenyl)bicyclo[2.2.1]heptan-2β-ol
|
|
|
|
|
(1R,4R,7-syn)-6β-Bromospiro[bicyclo[2.2.1]heptane-3,2'-[1,3]dioxolane]-7-carboxylic acid methyl ester
|
|
|
|
|
(1R,4R,7-syn)-6β-Bromo-3-oxobicyclo[2.2.1]heptane-7-carboxylic acid methyl ester
|
|
|
|
|
[1R,4R,7-syn,(-)]-Bicyclo[2.2.1]heptane-2α,7-diol 2-acetate
|
|
|
|
|
(1’R,2R)-2-(2’-Tosyl-1’,2’-dihydroxyethyl)-6-fluorochromane
|
(1’R,2R)-2-(2’-Tosyl-1’,2’-dihydroxyethyl)-6-fluorochromane
|
303176-46-7
|
C18H19FO5S
|
|
(1R,5R)-9-tosyl-9-azabicyclo[3.3.1]nona-2,6-diene
|
|
35985-98-9
|
C15H17NO2S
|
|
(R)-(S)-JOSIPHOS
|
(R)-(-)-1-[(S)-2-二苯基磷]二茂铁乙基二环己基磷
|
155806-35-2
|
C36H44FeP210*
|
|
(RS)-KETOPROFEN, [3H(G)]
|
|
|
C16H13O3T
|
|
(1R,5R,8S)-8-[(Z)-2-Pentenyl]-2-oxabicyclo[3.2.1]octan-3-one
|
|
|
C12H18O2
|
|
(2R,3R,4S,5Z)-2,3,4-Trimethoxy-6-(trimethylsilyl)-5-hexenal
|
|
|
C12H24O4Si
|
|
(1R,2R)-trans-2-(1-Piperidinyl)
cyclohexylaMine
|
(1R,2R)-TRANS-2-(1-PIPERIDINYL) CYCLOHEXYLAMINE
|
885677-91-8
|
C11H22N2
|
|
(1R,2R)-trans-2-AMino-1,2-dihydro-1-naphthol hydrochloride
|
(1R,2R)-反式-2-氨基-1,2-二氢-1-萘酚 盐酸盐
|
904316-35-4
|
C10H12ClNO
|
|
(1R,2R)-trans-2-AMino-1,2,3,4-tetrahydro-1-naphthol hydrochloride
|
(1R,2R)-反式-2-氨基-1,2,3,4-四氢-1-萘酚 盐酸盐
|
115563-64-9
|
C10H14ClNO
|
|
(1R,2R)-trans-1,2,3,4-Tetrahydro-1,2-naphthalenediol
|
(1R,2R)-反式-1,2,3,4-四氢-1,2-萘二醇
|
57496-61-4
|
C10H12O2
|
|
(1R,2R)-trans-1-Hydroxy-1,2-dihydro-2-naphthyl benzoate
|
(1R,2R)-反式-1-羟基-1,2-二氢-2-苯甲酸萘酯
|
337376-51-9
|
C17H14O3
|
|
(1R,2R)-trans-2-(Boc-aMino)-1,2-dihydro-1-naphthol
|
(1R,2R)-反式-2-(BOC-氨基)-1,2-二氢-1-萘酚
|
904316-32-1
|
C15H19NO3
|
|
(1R,2R)-trans-1-Hydroxy-1,2,3,4-tetrahydro-2-naphthyl benzoate
|
(1R,2R)-反式-1-羟基-1,2,3,4-四氢-2-萘基苯甲酸酯
|
904316-40-1
|
C17H16O3
|
|
(1R,2R)-trans-2-(Boc-aMino)-1,2,3,4-tetrahydro-1-naphthol
|
(1R,2R)-反式-2-(BOC-氨基)-1,2,3,4-四氢-1-萘酚
|
904316-33-2
|
C15H21NO3
|
|
(-)-(1R,2R)-trans-2-(hydroxyMethyl)cyclohexanoic acid
|
|
65376-04-7
|
C8H14O3
|
|
(1R,2R)-trans-2-(1-Piperidinyl)
cyclohexylaMine hydrochloride
|
|
|
C11H23ClN2
|
|
(2R 3R)-TRANS-3-PHENYLOXIRANE-2-METHANOL
|
|
|
C9H10O2
|
|
(1R,2R)-trans-N-Boc-1,2-Cyclohexanediamine
|
1R,2R-N-BOC-环己二胺
|
146504-07-6
|
C11H22N2O2
|
|
5-[3(R)-[[(2(R)-trans-Methyl-1,1-dioxotetrahydro-3(S)-thienyloxy)carbo nyl]amino]-4-(phenylthio)-2(R)-hydroxybutyl]-N-(1,1-dimethylethyl)octa hydrothieno[3,2-c]pyridine-6(R)-carboxamide
|
|
169273-55-6
|
C28H43N3O6S3
|
|
(2R, 4R)-TRANSHOMOPRO(4-OH)-OME
|
|
|
C7H13NO3
|
|
(1R,2R)-(-)-TRANS-1-AMINO-2-INDANOL
|
(1R,2R)-1-氨基-2-茚满醇
|
163061-73-2
|
C9H11NO
|
|
(-)-(2R,3R)-TRANS-2-HYDROXY-3-(4-PHENYLPIPERIDINO)-5-(2-FLUOROETHOXY)-TETRALIN
|
|
153215-70-4
|
C23H28FNO2
|
|
(R,R)-3,4-TRANS-(N-BOC)-DIAMINOPYRROLIDINE
|
TRANS TERT-BUTYL 3,4-DIAMINOPYRROLIDINE-1-CARBOXYLATE
|
161723-00-8
|
C14H27N3O4
|
|
(1R,2R)-TRANS-1,2-CYCLOHEXANEDIOL
|
1R,2R)-反-1,2-环己HEXANEDIOL
|
1072-86-2
|
C6H12O2
|
|
(1R,2R)-TRANS-1,2-CYCLOPROPANE DICARBOXYLIC ACID MONOETHYL ESTER
|
|
|
C7H10O4
|
|
(-)-(2R,3R)-TRANS-2-HYDROXY-3-(4-PHENYLPIPERIDINO)-5-(2-TOSYLOXYETHOXY)-TETRALIN
|
|
153215-71-5
|
C30H35NO5S
|
|
(2R,5R)-(-)-TRANS-2,5-DIMETHYLPYRROLIDINE
|
(2R,5R)-(-)-反-2,5-二甲基吡咯烷
|
62617-70-3
|
C6H13N
|
|
(1R,2R)-trans-2-Benzyloxycyclohexylamine hydrochloride
|
|
|
C13H20ClNO
|
|
(R,R)-TRANS-2-(4-BROMO-BENZOYL)-CYCLOPENTANECARBOXYLIC ACID
|
|
|
C13H13BrO3
|
|
(1R,2R)-TRANS-1,2-DIAMINOCYCLOHEXANE
|
|
|
C6H14N2
|
|
(1R,2R)-trans-N-Boc-2-Aminocyclohexanol
|
(1R,2R)-TRANS-N-BOC-2-AMINOCYCLOHEXANOL
|
155975-19-2
|
C11H21NO3
|
|
(1R,2R)-trans-1,2-Cyclopentanediamine dihydrochloride
|
(1R,2R)-反式-1,2-环戊烷二胺 二盐酸盐
|
1030390-38-5
|
C5H13ClN2
|
|
2(R)-[2(R)-(((trans-4-(1-Methylethyl)cyclohexyl)carbonyl)amino)-3-phenyl propionamido]-3-phenyl propionic acid.
|
|
|
C28H36N2O4
|